1887

Abstract

The objective of the study was to compare the proportions of the recovery of pathogens of acute maxillary sinusitis in adults in the 4-year period prior to the 5-year period that followed the introduction of vaccination of children with the 7-valent pneumococcal vaccine (PCV7). Cultures were obtained through endoscopy from 385 adults with acute maxillary sinusitis, 156 between 1997 and 2000, and 229 between 2001 and 2005. One hundred and seventeen potentially pathogenic organisms were isolated from the cultures obtained between 1997 and 2000. The predominant organisms were (54 or 46 % of all isolates), non-type b (42 or 36 %), (7 or 6 %), (8 or 7 %) and (6 or 5 %). One hundred and sixty-seven potentially pathogenic organisms were isolated from the cultures obtained between 2001 and 2005. The most predominant organisms were non-type b (71 or 43 % of all isolates), (58 or 35 %), (13 or 8 %), (12 or 7 %) and (13 or 8 %). Significant statistical differences were noted in the rates of recovery of non-type b (<0.05) and (<0.05). A decrease occurred in the recovery of resistant to penicillin from 41 to 29 %, and an increase was noted in the isolation of beta-lactamase-producing from 33 to 39 %; however, neither change was statistically significant. These data illustrate that a significant shift occurred in the causative pathogens of acute maxillary sinusitis in adults in the 5 years after the introduction of vaccination of children with the PCV7 compared to the previous 4 years.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46346-0
2006-07-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/7/943.html?itemId=/content/journal/jmm/10.1099/jmm.0.46346-0&mimeType=html&fmt=ahah

References

  1. Block, S. L., Hedrick, J., Harrison, C. J., Tyler, R., Smith, A., Findlay, R. & Keegan, E. ( 2004; ). Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23, 829–833.[CrossRef]
    [Google Scholar]
  2. Brook, I. ( 2005; ). Microbiology and antimicrobial management of sinusitis. J Laryngol Otol 119, 251–258.
    [Google Scholar]
  3. Brook, I. & Gober, A. E. ( 2004; ). Antimicrobial resistance in the nasopharyngeal flora of children with acute maxillary sinusitis and maxillary sinusitis recurring after amoxicillin therapy. J Antimicrob Chemother 53, 399–402.[CrossRef]
    [Google Scholar]
  4. Brook, I., Frazier, E. H. & Foote, P. A. ( 1996; ). Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol 45, 372–375.[CrossRef]
    [Google Scholar]
  5. Casey, J. R. & Pichichero, M. E. ( 2004; ). Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 23, 824–828.[CrossRef]
    [Google Scholar]
  6. Craig, W. A. & Andes, D. ( 1996; ). Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 15, 255–259.[CrossRef]
    [Google Scholar]
  7. Dagan, R. ( 2004; ). The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis media. Curr Opin Otolaryngol Head Neck Surg 12, 488–494.[CrossRef]
    [Google Scholar]
  8. Givon-Lavi, N., Fraser, D. & Dagan, R. ( 2003; ). Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J 22, 524–532.
    [Google Scholar]
  9. Murray, P. R., Barron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H. ( 1995; ). Manual of Clinical Microbiology, 6th edn. Washington, DC: American Society for Microbiology.
  10. National Committee for Clinical Laboratory Standards ( 1995; ). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. NCCLS document M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards.
  11. National Committee for Clinical Laboratory Standards ( 2000; ). MIC testing supplemental tables (M 100-S10). Wayne, PA: National Committee for Clinical Laboratory Standards.
  12. O'Brien, K. L. & Dagan, R. ( 2003; ). The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 21, 1815–1825.[CrossRef]
    [Google Scholar]
  13. O'Callaghan, D. H., Morris, A., Kirby, S. M. & Shingler, A. H. ( 1972; ). Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1, 283–288.[CrossRef]
    [Google Scholar]
  14. Pichichero, M. E. & Pichichero, C. L. ( 1995; ). Persistent otitis media: I causative pathogen. Pediatr Infect Dis J 14, 178–183.[CrossRef]
    [Google Scholar]
  15. Sinus and Allergy Health Partnership ( 2004; ). Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 130 (supplement 1), 1–45.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46346-0
Loading
/content/journal/jmm/10.1099/jmm.0.46346-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error